A toxin associated with Toxoplasma gondii infection was obtained from the trophozoites and culture medium used to propagate the parasite in cell cultures. The toxin, named Toxofactor (TF), administered parenterally or nonparenterally in adult mice, produces transient symptoms of lethargy, ruffled fur, and body weight loss. Organ changes which accompanied the outward symptoms included hepatospenomegaly and involuted thymus. TF activity was detected in extracts of the blood, peritoneal fluid, liver, and spleen of infected mice. Severe damage to embryonal and fetal development was induced when TF was administered during pregnancy. Resorption, abortion, and congenital abnormalities were produced, dependent upon the stage of development at the time of exposure. Adult mice which had reacted to and recovered from an initial intraperitoneal injection to TF were protected against a secondary challenge from TF. Fetal development was also protected from damage when TF was used to challenge adults previously exposed to TF. Mouse and rabbit anti-TF sera neutralized TF activity in the adult. In no instance did control mice show any deleterious effect when exposed to soluble cell lysate from the uninfected cell line (BHK-21) used to propagate the organism plus the used medium from these same uninfected cells. TF activity was not attributed to bacterial, mycoplasmal, or viral contamination. TF toxic activity is labile to elevated temperature and high or low pH, which also destroy its protective properties. TF activity was sensitive to trypsin and was obtained in the elution fraction (ox-methyl-D-mannoside) from affinity chromatography (concanavalin A-Sepharose 4B). Ultrafiltration indicated the molecular weight to be between 50,000 and 100,000. TF, apparently a glycoprotein, was quantitated for activity by a weight loss assay. A unit of activity was defined as the minimum quantity of TF (highest dilution) which produced at least a 10% average body weight loss in adult Nya:NYLAR female mice between days 7 and 12 postintraperitoneal injection.
The protozoan parasite Toxoplasma gondii is the causative agent of toxoplasmosis. A postnatally acquired T. gondii infection is usually of limited latency and mild effect, except when occurring in immunosuppressed individuals (21) or perhaps in human (24) or animal (22) juveniles.
A primary T. gondii infection during pregnancy, however, although producing mild clinical symptoms or none at all in the mother, can be extremely detrimental to the successful outcome of the pregnancy. Severe reproductive losses have been particularly well documented in sheep and have been observed in experimental infections (15) . The incidence of acquired toxoplasmosis in pregnant women and the implications for reproductive failure are still uncertain (5) , but when pregnancy has been maintained to term, congenital defects and abnormalities have been observed. Although congenital toxoplasmosis resulting in defects in newborns occurs with natural and experimental infection in animals (1, 2, 8, 11, 16) , the clinical manifestations have been described in more detail in humans (3, 4, 7, 19) .
The pathogenic mechanism(s) responsible for the wide range of symptoms associated with toxoplasmosis is not completely understood. The leukocytic granules observed by Huldt (18) in rabbits acutely infected with T. gondii resemble granules found in humans suffering from a wide range of toxic conditions (12) . Huldt, therefore, suggested that the cellular damage may be due to a toxic condition associated with the T. gondii infection. Inflammatory processes appear to be involved in some latent cases of congenital toxoplasmosis (7) .
Giroud et al. (11) suggested that cataracts in rats born to mothers infected with T. gondii during pregnancy may have been caused by a toxin resulting from the infection. Severe abnormalities of the central nervous system of chicken embryos exposed to toxoplasmin (6) were described by Lutz-Ostertag and Senaud (20) . A toxic product originally described by Weinman and Klatchko (23) was lethal when injected intravenously (i.v.) into mice. The nature of this material as a true toxin and how it relates to the pathogenesis of toxoplasmosis have not been resolved. However, several reports indicate that chronic conditions can occur in rats (10) and rabbits (17) exposed to toxotoxin as adults.
Here we describe our findings regarding some biological and physical properties of a cell-free toxinlike material we have termed Toxofactor (TF), which appears to be an important component in the pathogenesis of congenital toxoplasmosis.
(This paper was presented in part at the 83rd As a control, the medium (CM) from uninfected BHK-21 cultures was poured from the flasks into a container. Each flask was rinsed with 10 ml of water, which was added to the used medium. Another 10 ml of water was added to each flask, which was then capped, incubated overnight at 37°C, and added to the used medium, which was then handled exactly like medium from T. gondii infected cultures.
Weight loss assay for TF activity. An in vivo weight loss assay (WLA) was developed to test the effect of TF on mice. A unit of activity was defined as the amount of TF which produced an average body weight loss of at least 10% in mice for at least 2 consecutive days between days 7 and 12 after intraperitoneal (i.p.) injection.
The test materials were held on ice, diluted as necessary with PBS (pH 7.2), and dispensed with Drummond Dialamatic Microdispensers (Drummond Scientific Co., Broomall, Pa.). Medium containing TF or CM was injected into the mice the same day the dilutions were made. The mice were first weighed on an electronic top-loading balance (Mettler Instruments Corp., Hightstown, N.J.) and then inoculated immediately i.p. via sterile 1-ml tuberculin syringes and 26-gauge, 3/8-in. (0.96 cm) needles. In most instances, weights were determined only on the day of injection (day 0) and days 7 through 12 postinjection.
Recovery of TF from infected mice. Four adult female mice were each injected i.p. with approximately 107 trophozoites obtained from mice similarly injected 3 days earlier. On day 3 after injection, pooled extracts of blood, peritoneal cavity rinse, liver, and spleen, as combined from the four mice, were tested for TF activity by WLA as follows: The mice were anesthetized, bled from the retro-orbital plexus, and then killed by cervical dislocation; the livers and spleens were excised and disrupted with Dounce manual homogenizers. The suspensions from each of these three tissue sources and from the peritoneal cavity rinse were centrifuged at 5,000 x g at 4°C for 10 min. The supernatants were pipetted out of the centrifuge tubes into polypropylene test tubes and held on ice. Deionized water (5 ml) was added to each pellet from the extract of blood and the peritoneal cavity rinse, and the pellets were then vigorously vortexed for several minutes. These suspensions were then recentrifuged as described above, and the resulting supernatants were combined with the earlier respective supernatants. The supernatants from all four tissue or cell sources were then sterilized by filtration (pore diameter, 0.45 ,um) and tested for TF activity.
Partial purification of TF by lectin affinity chromatography. Medium containing TF was placed directly onto concanavalin A (ConA)-Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, N.J.) columns equilibrated with PBS. TF or CM medium was passed through the column at room temperature, and the flow was stopped for 1 h. PBS was added, and the first 10-ml void volume was collected, as was a fraction after five void volumes (50 ml) had passed through the column. The flow rate was adjusted to about 0.5 ml/min. a-Methyl-D-mannoside (0.5 M) in PBS was added and allowed to pass through the column. The flow was stopped for 2 3 weeks apart. Blood (10 ml) was taken from peripheral ear veins 3 weeks after the last injection, and the serum was processed and stored frozen (-20°C). Mouse anti-ConA-TF serum was produced by three biweekly i.p. injections of approximately 104 WLA units each. Three weeks after the last injection, the mice were bled by decapitation. The pooled sera were processed and stored frozen (-20°C) . AntiConA-CM was produced similarly.
Lability of TF and ConA-TF to heat and pH changes. Medium containing TF was placed for up to 1 h in a 56 or 37°C water bath. Samples were removed at intervals for WLA. A volume of TF was held at 4°C as the test control.
To determine the lability of TF and ConA-TF at pH 2, 5, 7, 9, and 12, the solutions were adjusted to pH 2 or 5 with 1 M HCI and to pH 9 or 12 with 1 M NaOH. The material was refrigerated overnight and then neutralized with 1 M NaOH or 1 M HCI. CM and ConA-CM were treated similarly. Refrigerated TF fractions (pH 7.0) were used to establish TF activity.
Centrifugation of TF and ConA-TF. For further characterization, TF and ConA-TF were centrifuged in cellulose nitrate tubes at 100,000 x g for 1 h in an L5-65B ultracentrifuge (Beckman Instruments, Inc., Palo Alto, Calif.) with a SW50.1 rotor. As a control, tubes with TF medium were held without centrifugation at 4°C for the same period. The supernatants were removed, and the tubes were rinsed with 5 volumes of PBS. Then 2 ml of PBS was added per tube, and the tubes were vortexed for several minutes. The supernatant and rinse were tested for TF activity by WLA. Sonication of purified trophozoites. Trophozoites propagated in the BHK-21 cell line were purified by glass-fiber filtration (13) (Fig. 1) . For most other experiments, weights were determined only on the day of injection (day 0) and days 7 through 12 postinjection.
As shown in Fig. 1 , the mice injected with CM diluted 100-fold tended to gain weight during the test period, as did noninjected mice or mice injected with undiluted CM or PBS only (data not shown). Typically, mice exposed to higher concentrations of TF tended to respond more quickly and recover body weights more quickly ( Fig. 1 Mice responding to TF with the symptoms just described also experienced changes in certain organs. Three groups of mice exposed i.p. were killed on days 7, 14, and 21, and their livers, spleens, and thymi were excised and weighed. Compared to uninjected control livers, the mean weights were 27.5% heavier by day 14 after treatment with TF but were in the normal range by day 21 (Table 1 ). The spleen mean weight was doubled by day 7 and had not returned to normal by day 21. The thymus was involuted in TF-exposed mice, the mean weight on day 7 being less than half that of noninjected controls. Thymi of CM-injected mice were heavier on days 7 and 14 than those of uninjected controls on day 0.
Detection of TF in organs of infected mice. TF activity was detected in extracts of blood, peritoneal fluid, liver, and spleen of infected mice. Reproduction losses. Injection of TF just before pairing (day 0) completely prevented the delivery of litters conceived within 2 weeks of the treatment and pairing (Fig. 2) . Exposed females which carried to term as a result of conception in week 3 produced fewer animals per litter (5.8) than the CM-injected controls (9.2). When 1 WLA TF unit was injected on day 0, reproduction losses were less severe than with higher doses ( Table 2) .
Administration of TF by intragastric intubation on day 0 was less effective, with approximately half of the animals delivering litters as a result of conception in week 1 after treatment and pairing, and the other half delivering litters as a result of conception in week 3 (Fig. 2) Failure to obtain "toxotoxin" from TF-sick mice. Although i.v. administration of TF to mice produced the transient toxic symptoms, the possibility was examined whether in these mice TF may be converted or complexed with mouse products to produce the lethal "toxotoxin" (23) .
Mice were injected i.p. with 104 WLA units of TF. They were killed 7 days later, and their peritoneal cavities were rinsed with 1 ml of PBS. These washings, injected i.v. into healthy, nonimmune mice, were neither lethal within minutes, as reported for toxotoxin, nor produced the transient toxic symptoms of TF.
No evidence that TF is a microorganism. All attempts to identify a microorganism as TF failed. Each lot of TF medium and CM was passed through 0.22-,um filters. Contamination by bacteria, mycoplasma, or virus was ruled out. Furthermore, TF activity was not maintained when TF medium was inoculated into uninfected BHK-21 cultures. After 1 week at 37°C, no TF activity could be detected by WLA.
Affinity chromatography. The results from ConA-Sepharose 4B affinity chromatography indicated that TF was retained on the column and eluted with a-methyl-D-mannoside. When a sufficient volume of TF medium was added to the column, TF could be found in the first void volume. No TF activity was detected in subsequent void volumes eluted with PBS. When amethyl-D-mannoside was then passed through the column, TF was recovered in the elution void volume, as determined by WLA. Approximately a 10-fold increase in purity (5 x Chemical and physical properties of TF. Exposure of TF or ConA-TF to 56°C for as little as 30 min destroyed its toxicity ( Table 6 ).
The pH extremes of 2 and 12 (for 18 h at 8°C) inactivated TF. TF activity was reduced at pH 5 but was retained at neutral pH and up to pH 9 (Table 6 ). ConA-TF activity was lost at pH 5 and 9.
TF activity was reduced by trypsin. Heating at 37°C for 4 h eliminated 75% of TF activity in the absence of trypsin and 90% in the presence of trypsin. Separation techniques were used to further characterize TF. After centrifugation at 100,000 x g for 1 h, approximately 50% of the original TF activity was recovered in the supernatant. Even though no pellets were visible in the cellulose nitrate centrifugation tubes, the remaining TF activity was recovered after thorough vortexing of the rinse tubes. However, similar tubes with TF added and held at 4°C for 1 The chemical and physical characterization of TF has been initiated. The apparent sensitivity to trypsin proteolysis must be regarded with caution, since partial loss of activity was produced by incubation in the absence of trypsin. TF appears to be a glycoprotein, as determined by its apparent sensitivity to trypsin, its retention on ConA-Sepharose 4B columns, and its elution by at-methyl-D-mannoside. Ultrafiltration tentatively places its molecular weight at 50,000 to 100,000. TF was recovered in both the 100,000 x g supernatant and vortexed tube washing (no pellet observed) fractions. The de- The lability of TF activity to heat and the size of TF indicate that it is not the same material as toxotoxin, as originally described by Weinman and Klatchko (23) . Toxotoxin is found in the cell-free peritoneal exudate of mice acutely infected with T. gondii. It is heat stable and apparently part of a large-molecular-weight (>800,000) complex (9) . The mode of action of toxotoxin is generally limited to a fast (within minutes) lethal result in mice injected i.v. TF is highly protective against the effects of a secondary exposure; toxotoxin is not.
The protection afforded by a prior exposure to TF is essentially complete, at least in the Nya:NYLAR mouse. The mice in our studies which experienced symptoms after the primary TF exposure did not experience symptoms after TF challenge. Reproduction losses were also prevented by exposing females to TF 5 to 6 weeks before mating and challenge. The long duration (at least 242 days) of protection provided by active vaccination and the passive protection provided by rabbit and mouse anti-TF serum suggests that humoral factor(s) may be the main protective mechanism(s).
Investigators (1, 11, 16) have shown experimentally that T. gondii infection of mice and rats during pregnancy can reduce reproduction rates and that the surviving offspring will exhibit congenital defects. The teratogenic nature of toxoplasmin (6) , as reported by Lutz-Ostertag and Senaud (20) for chicken embryos, may be associated with pathogenic mechanisms of abnormal fetal development in natural T. gondii infections. In the present study, the supernatant of ST propagated from cell cultures induced symptoms identical to those induced by TF and was cross-protective. It is possible that the teratogenic material used by Lutz-Ostertag and Senaud (20) contained TF.
Among the few microorganisms known as teratogens to the human fetus, only T. gondii lacks species specificity. Experimental animal models are thus available to study the pathogenic mechanisms associated with congenital T. gondii infections. The immunogenic responses which protect the fetus against abnormal development in the immunized female are also amenable to investigation. We believe that TF will prove to be highly useful to investigating both of these concerns.
